Cargando…
Curcumin inhibits hepatocellular carcinoma growth by targeting VEGF expression
Morbidity and mortality owing to hepatocellular carcinoma (HCC), the most common primary liver cancer, has increased in recent years. Curcumin is a polyphenol compound that has been demonstrated to exert effective antiangiogenic, anti-inflammatory, antioxidant, and antitumor effects. However, its cl...
Autores principales: | Pan, Zirong, Zhuang, Jianmin, Ji, Chenghong, Cai, Zhezhen, Liao, Weijia, Huang, Zhengjie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5840714/ https://www.ncbi.nlm.nih.gov/pubmed/29552121 http://dx.doi.org/10.3892/ol.2018.7988 |
Ejemplares similares
-
Impact of liver fibrosis score on prognosis after common therapies for intrahepatic cholangiocarcinoma: a propensity score matching analysis
por: Zhang, Jian Xi, et al.
Publicado: (2020) -
SPAG5, the upstream protein of Wnt and the target of curcumin, inhibits hepatocellular carcinoma
por: Li, Huiyang, et al.
Publicado: (2023) -
Downregulation of miRNA-638 promotes angiogenesis and growth of hepatocellular carcinoma by targeting VEGF
por: Cheng, Jiwen, et al.
Publicado: (2016) -
Efficacy of curcumin in inducing apoptosis and inhibiting the expression of VEGF in human pterygium fibroblasts
por: Lu, Cheng-Wei, et al.
Publicado: (2017) -
miR-455 Inhibits the Viability and Invasion by Targeting RAB18 in Hepatocellular Carcinoma
por: Wang, Chenghong, et al.
Publicado: (2021)